Collegium Pharmaceutical Inc. (COLL) Share Price Today, Stock Analysis, Annual Report | Value Research Collegium Pharmaceutical Inc. (COLL) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial report.

Collegium Pharmaceutical Inc. (COLL)

Download Stock Report

NASDAQ: COLL

  • Price Change
  • Market Capitalisation market-capitalisation-info $748 Mln

  • 12 Month Earnings monthly-earning $-29 Mln
  • Price to Earnings price-to-earning --

Collegium Pharmaceutical Inc. (COLL) Share Price

$22.76

As on 02-Oct-2023 16:00 EDT

up-down-arrow $0.411.83%

  • Prev Close info

    $22.35

  • Day's Openinfo

    $22.32

  • Today's Highinfo

    $22.83

  • Today's Lowinfo

    $22.26

  • Today's Volumeinfo

    240,511

Please wait...

Collegium Pharmaceutical Inc. (COLL) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Collegium Pharmaceutical (COLL)
-1.90 -4.13 5.91 42.07 1.63 8.80 --
S&P BSE Sensex*
7.71 0.22 1.26 14.11 19.20 12.40 12.88
S&P BSE Healthcare#
23.72 2.78 10.39 22.09 12.74 13.60 11.62
As on 02-Oct-2023  |  *As on 03-Oct-2023  |  #As on 03-Oct-2023
2022
2021
2020
2019
2018
2017
2016
Collegium Pharmaceutical (COLL)
24.20 -6.74 -2.67 19.86 -6.95 18.56 -43.38
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Collegium Pharmaceutical Inc. (COLL) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Collegium Pharmaceutical Inc. (COLL)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Co-Founder & Chairman

        Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.

        Pres, CEO & Director

        Mr. Joseph J. Ciaffoni

        Headquarters

        Stoughton, MA

        FAQs for Collegium Pharmaceutical Inc. (COLL)

        The total asset value of Collegium Pharmaceutical Inc. (COLL) stood at $ 1,627 Mln as on 31-Mar-23

        The share price of Collegium Pharmaceutical Inc. (COLL) is $22.760000 (NASDAQ) as of 02-Oct-2023 16:00 EDT. Collegium Pharmaceutical Inc. (COLL) has given a return of 1.63% in the last 3 years.

        Collegium Pharmaceutical Inc. (COLL) has a market capitalisation of $ 748 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of Collegium Pharmaceutical Inc. (COLL) is 3.86 times as on 02-Jun-2023, a 0.37% premium to its peers’ median range of 2.82 times.

        Since, TTM earnings of Collegium Pharmaceutical Inc. (COLL) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Collegium Pharmaceutical Inc. (COLL) and enter the required number of quantities and click on buy to purchase the shares of Collegium Pharmaceutical Inc. (COLL).

        Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

        The CEO & director of Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.. is Collegium Pharmaceutical Inc. (COLL), and CFO & Sr. VP is Mr. Joseph J. Ciaffoni.

        The promoters of Collegium Pharmaceutical Inc. (COLL) have pledged 0% of the total equity as on Dec-22.

        Collegium Pharmaceutical Inc. (COLL) Ratios
        Return on equity(%)
        -15.58
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        3.42
        Dividend yield(%)
        0

        No, TTM profit after tax of Collegium Pharmaceutical Inc. (COLL) was $-29 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $748.29 Mln
        • Revenue (TTM)revenue-information $524.95 Mln
        • Earnings (TTM) earning-information $-29.36 Mln
        • Cash date-information $269.48 Mln
        • Total Debt info $806.24 Mln
        • Insider's Holding 1.02%
        • Liquidity liquidity High
        • 52 Week range week-range $15.92 - 30.22
        • Shares outstanding share-outstanding 34,594,800
        • 10 Years Aggregate:

          CFO: $320.79 Mln

          EBITDA: $-156.13 Mln

          Net Profit: $-91.77 Mln

        About The Company

        • IPO Date 07-May-2015
        • Co-Founder & Chairman Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
        • Pres, CEO & Director Mr. Joseph J. Ciaffoni
        • Listing key-listing NASDAQ: COLL
        • Country United States
        • Headquarters headquarters Stoughton, MA
        • Website website https://www.collegiumpharma.com
        • Business

          Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe...  enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon